These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 18413768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Non-redundant role for IL-7R signaling for the survival of CD8+ memory T cells.
    Carrio R, Rolle CE, Malek TR.
    Eur J Immunol; 2007 Nov; 37(11):3078-88. PubMed ID: 17935075
    [Abstract] [Full Text] [Related]

  • 4. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA.
    Cancer Res; 2004 Nov 01; 64(21):8062-7. PubMed ID: 15520217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z, Shi M, Chan T, Sas S, Xu S, Xiang J.
    Cancer Gene Ther; 2007 Jul 01; 14(7):661-75. PubMed ID: 17479109
    [Abstract] [Full Text] [Related]

  • 10. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE, Redmond WL, Haley D, Weinberg AD.
    Eur J Immunol; 2007 Jan 01; 37(1):157-66. PubMed ID: 17183611
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo.
    Perret R, Ronchese F.
    Eur J Immunol; 2008 Oct 01; 38(10):2886-95. PubMed ID: 18825745
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phase.
    Shi M, Ye Z, Umeshappa KS, Moyana T, Xiang J.
    Biochem Biophys Res Commun; 2007 Aug 31; 360(3):702-7. PubMed ID: 17618911
    [Abstract] [Full Text] [Related]

  • 15. Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
    Nishimura F, Dusak JE, Eguchi J, Zhu X, Gambotto A, Storkus WJ, Okada H.
    Cancer Res; 2006 Apr 15; 66(8):4478-87. PubMed ID: 16618775
    [Abstract] [Full Text] [Related]

  • 16. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.
    Kim EY, Teh SJ, Yang J, Chow MT, Teh HS.
    J Immunol; 2009 Nov 15; 183(10):6051-7. PubMed ID: 19841176
    [Abstract] [Full Text] [Related]

  • 17. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abdulsamad K, Adams SL.
    Immunol Invest; 2008 Nov 15; 37(4):315-38. PubMed ID: 18569073
    [Abstract] [Full Text] [Related]

  • 18. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
    Yi KH, Nechushtan H, Bowers WJ, Walker GR, Zhang Y, Pham DG, Podack ER, Federoff HJ, Tolba KA, Rosenblatt JD.
    Cancer Res; 2007 Oct 15; 67(20):10027-37. PubMed ID: 17942937
    [Abstract] [Full Text] [Related]

  • 19. Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity.
    Tao J, Segal BH, Eppolito C, Li Q, Dennis CG, Youn R, Shrikant PA.
    J Leukoc Biol; 2006 Sep 15; 80(3):529-37. PubMed ID: 16793916
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
    Mueller K, Schweier O, Pircher H.
    Eur J Immunol; 2008 Oct 15; 38(10):2874-85. PubMed ID: 18825743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.